| HRG |
HRG: Histidine-rich glycoprotein precursor |
CTSG |
CTSG: Cathepsin G precursor |
1.675 |
Evidence |
|
| SLPI |
SLPI, WAP4, WFDC4: Antileukoproteinase precursor |
CST7 |
CST7: Cystatin-F precursor |
1.675 |
Evidence |
|
| SLPI |
SLPI, WAP4, WFDC4: Antileukoproteinase precursor |
C6 |
C6: Complement component C6 precursor |
1.675 |
Evidence |
|
| SLPI |
SLPI, WAP4, WFDC4: Antileukoproteinase precursor |
SERPINA5 |
SERPINA5, PCI, PLANH3, PROCI: Plasma serine protease inhibitor precursor |
1.675 |
Evidence |
|
| SLPI |
SLPI, WAP4, WFDC4: Antileukoproteinase precursor |
SERPINE1 |
SERPINE1, PAI1, PLANH1: Plasminogen activator inhibitor 1 precursor |
1.675 |
Evidence |
|
| MMP1 |
MMP1, CLG: Interstitial collagenase precursor |
GUCA2B |
GUCA2B: Guanylate cyclase activator 2B precursor [Contains: Guanylate cyclase C- |
1.675 |
Evidence |
|
| TF |
TF, PRO1400: Serotransferrin precursor |
PAPPA |
PAPPA, RP11-45A16.1-001: Pregnancy-associated plasma protein A, pappalysin 1 (Fr |
1.675 |
Evidence |
|
| TF |
TF, PRO1400: Serotransferrin precursor |
PAEP |
PAEP: Glycodelin precursor |
1.675 |
Evidence |
|
| PF4 |
PF4, CXCL4, SCYB4: Platelet factor 4 precursor |
RNASE4 |
ANG, RNASE5: Angiogenin precursor |
1.675 |
Evidence |
|
| ORM1 |
ORM1, AGP1: Alpha-1-acid glycoprotein 1 precursor |
HLA-DPB1 |
HLA-DPB1: MHC class II lymphocyte antigen beta chain precursor |
1.675 |
Evidence |
|
| ORM1 |
ORM1, AGP1: Alpha-1-acid glycoprotein 1 precursor |
CEACAM6 |
CEACAM6, NCA: Carcinoembryonic antigen-related cell adhesion molecule 6 precurso |
1.675 |
Evidence |
|
| ORM1 |
ORM1, AGP1: Alpha-1-acid glycoprotein 1 precursor |
CCL5 |
CCL5, D17S136E, SCYA5: Small-inducible cytokine A5 precursor |
1.675 |
Evidence |
|
| AMBP |
AMBP, HCP, ITIL: AMBP protein precursor [Contains: Alpha-1-microglobulin |
HLA-DPB1 |
HLA-DPB1: MHC class II lymphocyte antigen beta chain precursor |
1.675 |
Evidence |
|
| AMBP |
AMBP, HCP, ITIL: AMBP protein precursor [Contains: Alpha-1-microglobulin |
CEACAM6 |
CEACAM6, NCA: Carcinoembryonic antigen-related cell adhesion molecule 6 precurso |
1.675 |
Evidence |
|
| AMBP |
AMBP, HCP, ITIL: AMBP protein precursor [Contains: Alpha-1-microglobulin |
SERPINE1 |
SERPINE1, PAI1, PLANH1: Plasminogen activator inhibitor 1 precursor |
1.675 |
Evidence |
|
| APOH |
APOH, B2G1: Beta-2-glycoprotein 1 precursor |
DLG2 |
DLG2: Disks large homolog 2 |
1.675 |
Evidence |
|
| APOH |
APOH, B2G1: Beta-2-glycoprotein 1 precursor |
REG3A |
REG3A, HIP, PAP, PAP1: Regenerating islet-derived protein 3 alpha precursor |
1.675 |
Evidence |
|
| APOH |
APOH, B2G1: Beta-2-glycoprotein 1 precursor |
SPARC |
SPARC, ON: SPARC precursor |
1.675 |
Evidence |
|
| APOH |
APOH, B2G1: Beta-2-glycoprotein 1 precursor |
IL3 |
IL3: Interleukin-3 precursor |
1.675 |
Evidence |
|
| APCS |
APCS, PTX2: Serum amyloid P-component precursor |
SERPINE1 |
SERPINE1, PAI1, PLANH1: Plasminogen activator inhibitor 1 precursor |
1.675 |
Evidence |
|
| APOA2 |
APOA2: Apolipoprotein A-II precursor |
FSTL1 |
FSTL1, FRP: Follistatin-related protein 1 precursor |
1.675 |
Evidence |
|
| APOA1 |
APOA1: Apolipoprotein A-I precursor |
FSTL1 |
FSTL1, FRP: Follistatin-related protein 1 precursor |
1.675 |
Evidence |
|
| APOA1 |
APOA1: Apolipoprotein A-I precursor |
REG3A |
REG3A, HIP, PAP, PAP1: Regenerating islet-derived protein 3 alpha precursor |
1.675 |
Evidence |
|
| APOA1 |
APOA1: Apolipoprotein A-I precursor |
MMP13 |
MMP13: Collagenase 3 precursor |
1.675 |
Evidence |
|
| PIGR |
PIGR: Polymeric-immunoglobulin receptor precursor |
LTB4R |
LTB4R, BLT, BLT1, BLTR, CMKRL1, GPR16, P2RY7: Leukotriene B4 receptor 1 |
1.675 |
Evidence |
|